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Abstract 
 
 novel transaortic ventricular cannula, known as the 'double barrel' cannula 
(DBC), is designed to minimize the invasiveness of Ventricular Assist Device 
(VAD) implantation by combining the inlet and outlet cannulae into a single 
dual lumen cannula.  Both the inlet and outlet lumen will pass through a single opening 
in the apex of the left ventricle with the outflow then continuing past the aortic valve, into 
the aortic arch.  This design offers several potential advantages over the current state-
of-the-art.  The benefits of the DBC include less invasive surgery and providing 
mechanical support to the septum.  By routing the outflow through the aortic valve, the 
need to access the external structure of the ascending aorta at the time of implantation 
is eliminated thereby eliminating the need for open heart surgery.   
In designing the DBC, close attention has been paid to the outflow portion of the 
cannula since it was anticipated that this portion of the DBC could have the largest 
impact on the device’s usability.   The object of this study was to test the performance of 
the valve with the cannula passing through it.   Three different geometries of similar 
cross-sectional area were compared.  The geometries were circular, equilateral 
triangular, and occluded leaflet.  Experiments measuring aortic insufficiency (AI), 
hemolysis, and differential pressure across the valve were conducted.   Additionally, 
high speed cinematography was used to analyze the dynamics of the valve’s sealing to 
the cannulae. 
All three geometries exhibited low and acceptable levels of AI (≤ 15% AI), with 
the circular geometry causing the least amount of AI (7.1%) in comparison to the 
control, an aortic valve with no cannula (2.4%).  The hemolysis test results revealed that 
all three of the cannulae designs generated negligible hemolysis (<0.5% after one hour) 
as compared to the control case.  The pressure loss across the aortic valve was found 
to correspond to the area open to flow.  Using the high speed cinematography, several 
phenomena were observed during the sealing of the porcine valve; including leaflet 
folding, leaflet bunching, and cannula displacement due to valve closure. 
A
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1. Introduction 
 
1.1 Ventricular Assist Devices 
Ventricular Assist Devices (VAD) have been in clinical use since the 1980s and 
have helped thousands of people suffering from heart disease and chronic heart failure.  
They are implanted adjacent to the heart and supplement the heart’s natural pumping 
(Figure 1).  One of the drawbacks of implanting and removing a VAD is that the 
procedure involves a lengthy open-heart surgery that includes splitting and retracting 
the rib cage in order to gain full access to the thoracic cavity.  One way this could be 
avoided is to implant the VAD through an incision in the abdomen (Shimpo, Akira and 
Kazuya).  This study aims to design and test a cannula to facilitate this novel, less 
invasive surgical approach.  
Figure 1 - Conventional VAD Implant 
Adapted from (Heart Disease Health Center) 
Cannula 
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1.2 The Double Barreled Cannula 
Cannulae serve the function of delivering blood to the VAD and then back into 
the circulatory system.  In the case of the left ventricle (LV), the VAD attaches to the 
apex of the LV for the inflow, and at the ascending aorta for the outflow of the VAD 
(Figure 1) (Litwak, Koenig and Tsukui).  The cannulae in this study are meant to 
combine both the inflow and outflow cannulae into a single structure referred to as the 
“double-barrel cannula” (DBC) (Figure 2).  Both inlet and outlet lumen will pass through 
a single opening in the apex of the LV with the outflow then continuing past the aortic 
valve, into the aortic arch.  
This design offers several potential advantages over the current state-of-the-art.  
These include simpler surgery and providing mechanical support to the septum.  By 
routing the outflow through the aortic valve, the need to access the external structure of 
the ascending aorta during implantation surgery is eliminated and therefore open heart 
surgery is not necessary.  This would facilitate an abdominal surgical approach for 
implantation.  Traditionally, to access the aorta through the abdomen, the cannula 
attaches to the abdominal aorta.  The main issue with this approach is that it can cause 
Figure 2 - Double Barrel Cannula 
 Aortic Valve Performance with Transaortic Ventricular Cannula 3 
 
flow to regurgitate backwards across the aortic valve and into the heart leading to 
insufficient flow to the upper extremities (Litwak, Koenig and Tsukui).   
An additional benefit of the proposed design is the reduction of septal shift, 
movement of the wall that separates the left and right ventricle, which is seen when the 
VAD causes a negative pressure in the LV.  This is only a benefit if the interventricular 
septum is used as an anchor for the outflow extension of the DBC, in which case the 
DBC would essentially act as a ventricular stent (Massey). 
1.3 Cardiovascular Dynamics 
The cardiac cycle (Figure 3) refers to the phases that make up a complete 
heartbeat.  Looking specifically at the left side of the heart, first we will follow the blood 
path and then explore one complete cardiac cycle.  Oxygenated blood from the lungs is 
delivered to the left atrium via the pulmonary veins.  From the left atrium blood is 
Figure 3 - Cardiac Cycle 
(Wellsphere) 
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passed through the mitral valve into the left ventricle.  The left ventricle is the main 
driving chamber of the heart since from here blood is pumped to the rest of the body.  
Blood in the left ventricle then passes through the aortic valve into the aortic arch and 
on to the rest of the body.   
The cardiac cycle consists of two major phases: diastole and systole.  Diastole is 
the portion of the cycle where blood is being pumped from the left atrium to the left 
ventricle.  The mitral valve is open to allow the flow into the ventricle and the aortic 
valve is closed due to pressure in the aorta.  Once the left ventricle is full, the mitral 
valve closes, making the beginning of the systolic phase.  The contraction of the left 
ventricle causes the pressure in the ventricle to increase and eventually open the aortic 
valve.  The left ventricle ejects its blood volume into the aorta via the aortic valve.  Once 
the ventricle has fully contracted and begins to relax, the aortic valve will seal as a result 
of the aortic pressure being higher than the ventricular pressure and the diastolic phase 
will begin again. 
1.4 Aortic Valve 
The aortic valve is a one-way, pressure driven, tricuspid valve.  There are three 
leaflets, each cupped with the concave side facing the aorta, which enable the closing 
and sealing of the valve when aortic pressure causes the blood to flow back toward the 
ventricle (Geerts, Kerckhoffs and Bovendeerd) (Marieb and Hoehn).  The valve is open 
during the systolic phase of the cardiac cycle and allows blood to flow from the left 
ventricle to the aorta.  During diastole, the valve is sealed and prevents blood from 
leaking from the aorta to the ventricle.   
 Aortic Valve Performance with Transaortic Ventricular Cannula 5 
 
The aortic valve contains three leaflets which are named for the coronary arteries 
which originate behind them in the sinus of valsalva.  They are the Right Coronary 
Cusp, the Left Coronary Cusp, and the Non Coronary Cusp (Figure 4).  The leaflets 
come together along the sinotubular junction and meet at the commissures (Figure 5).  
In the midpoint of each leaflet, there is a nodule and when the valve is closed these 
nodules all meet in the center of the aortic valve.  The shape of the valve and 
positioning of the leaflets varies slightly from person to person.  The porcine cardiac 
tissue is an adequate substitute for human tissues  (Crick, Sheppard and Ho)  (Lim, 
Chew and Chew).  Due to the similarity and availability of the porcine tissues, a porcine 
aortic valve was used in this study. 
Figure 4 - Aortic Valve Anatomy 
Dissected View. Adapted from (Netter) 
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1.5 Aortic Insufficiency
During diastole, there is a higher pressure in the aorta (~100 mmHg) than within 
the ventricle (~10mmHg).  In a healthy functioning aortic valve, there i
the aortic valve during diastole.  In patients with heart disease, valve calcification, or a 
disease of the aortic valve, flow may 
diastole (Figure 6).  This is referred to as Aortic Regurgita
(AI).  AI traditionally is defined as the
volume ejected from the ventricle, and referred to as percent regurgitated
Nishimura).  For example, if the heart ejects 100
and 20 mL is leaked back into the ventricle during the diastolic phase, the pa
have a 20% AI.  
Clinically, AI is measured using an echocardiogram, which allows the doctors to 
determine the volumes by examining jet velocities 
geometries will be compared by this measure with the least percentage
insufficiency being beneficial.   
Figure 5
CEZO 
 
s no flow through 
regurgitate into the ventricle from the aorta during 
tion or Aortic Insufficiency 
 volume regurgitated into the ventricle divided by 
 (Bonow and 
 mL per contraction of the left ventricle 
through the aorta. The three
 of aortic 
 - Aortic Valve Anatomy Continued 
tient would 
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It was predicted that the equilateral triangular cross section would exhibit the 
least amount of aortic insufficiency.  This is due to the fact that each leaflet has a flat 
surface to seal against as opposed to the rounded surface of the circular cross section.  
Although the Occluded Valve cross section also has a flat surface to seal against, the 
flat edge lays adjacent to the leaflets . 
1.6 Hemolysis 
Hemoglobin is the chemical responsible for the blood’s ability to carry oxygen 
throughout the body and remove carbon dioxide.  In undamaged blood, hemoglobin is 
only found within the red blood cells.  If the red blood cell is ruptured or damaged, the 
hemoglobin, along with other contents of the cell, is released into the plasma.  It has 
been shown that hemoglobin found in the plasma, known as plasma-free hemoglobin 
(PfHb), is a good indicator of red blood cell rupture known as hemolysis.  By binding the 
hemoglobin with chemical reagents, the concentration of PfHb can be calculated by 
measuring the amount of light the test samples absorb at specific wavelengths.  The 
concentration of PfHb can then be used to calculate the Normalized Index of Hemolysis 
(NIH).  The NIH is a metric used in hematology to draw similarities between tests done 
in vitro and in vivo. 
Figure 6 - Aortic Insufficiency 
(CentraHealth) 
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Since the DBC passes through the aortic valve, it may interfere with the flow 
through this valve and introduce unacceptably high shear stress to the blood flow.  
Shear stress has been found to be a cause of hemolysis.  The amount of hemolysis is a 
function of both the turbulent shear stress and exposure time (Adrian) (Stien and 
Sabbah) (Escudier and Smith) (Grigioni, Daniele and D'Avenio).  Mechanical prosthetic 
heart valves have been shown to cause hemolysis due to high shear stresses occurring 
when the valve is closing between systole and diastole (Balducci, Grigioni and Querzoli) 
(Krafczyk, Cerrolaza and Schulz) (Grigioni, Daniele and Del Gaudio).  It is hypothesized 
that the DBC could introduce hemolysis by causing high shear stresses when the valve 
is closing.  The hope is to find that the device will not contribute to blood damage and 
that shear stresses experienced by the blood due to the DBC are acceptably low. 
1.7 Motivation 
1.7.1 Double Barrel Cannula Design 
This study serves as a way to refine and develop the design of the DBC.  By 
determining the shape of the outflow section, the DBC can be constructed for use in 
animal models.  The purpose of these experiments was to find a cross sectional 
geometry that enabled proper sealing between the aortic valve and the cannula.  This is 
important since the aortic valve holds back the pressure in the aorta.  A poorly 
functioning aortic valve decreases the cardiac output, requiring the ventricle to work 
harder.  By determining which geometry works best with the aortic valve, the design of 
the DBC can be finalized and used in further testing. 
1.7.2 Catheters 
Several different surgical techniques, such as femoral catheterization, require 
instrumentation to pass through the aortic valve.  The results of this research are also 
applicable to catheters used in mitral valve repair, coronary artery procedures, and stent 
placement, to name a few.  Currently, these tools cause a large increase in aortic 
insufficiency and therefore decrease blood flow to the body (Massey).  This reduced 
flow is tolerable for a short period, but can cause problems during lengthy procedures.  
 Aortic Valve Performance with Transaortic Ventricular Cannula 9 
 
For a longer procedure the patient may be put on extracorporeal cardio pulmonary 
bypass, a very invasive procedure with many risks.  A better understanding of the effect 
that an object placed in the aortic valve has on the valve’s function, the better these 
surgical tools can be designed to limit their effect.  This could lead to tools which enable 
longer or more complex procedures to be done, using a less invasive method of 
catheterization. 
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2. Methods 
  
2.1 Experiment Overview 
In order to quantitatively measure the performance of the aortic valve with the 
DBC’s outflow in place, the full cardiac cycle was mimicked with a physical bench top 
model to analyze the valve.  Natural aortic valves explanted from pig hearts were used 
in this study.  Three cross-sectional geometries of cannula were analyzed in a cyclic 
pulsatile flow.  The three geometries were compared to one another using the following 
metrics: aortic insufficiency, pressure drop, valve dynamics, and hemolysis.  
The experiment apparatus is a simple flow loop with a section made optically 
clear to enable imaging of the aortic valve and cannulae with a high speed camera.  The 
experiment analyzed several geometries passing through an aortic valve in pulsatile 
flow using two fluid mediums, phosphate buffered saline (PBS) and whole citrated 
bovine blood.  For the pulsatile flow, a pneumatic ventricle simulator was used to 
generate a mean flow rate of 6.4 L/min and peak aortic valve pressure differential of 90 
mmHg, both of which represent physiological flow.  Flow rate and differential pressure 
across the aortic valve were monitored during all testing. 
2.2   Double Barrel Cannula 
2.2.1  Cannulae Design 
The cross-sectional geometry designs were inspired by the shape of the aortic 
valve.  The equilateral triangular variation utilizes the fact that the valve has periodic 
symmetry and the cross section shares that same symmetry.  It was hypothesized that 
the equilateral triangular geometry would promote the valve’s ability to seal against the 
obstruction since it provides a flat surface to seal against (Figure 7).  The occluded 
valve leaflet geometry was meant to take up the space normally occupied by one of the 
12 
 
valve leaflets. Finally, the circular geometry represents the current design of catheters 
which pass through the aortic valve.
The scale of these geometries 
cross-sectional area held constant across the three geometries
occluded valve leaflet, the scale wa
in this study.  The occluded valve leaflet occupies
area and leaves the aortic valve with only two f
geometries were designed to have
the geometric equations for area of the respective shapes.
These experiments were conducted with solid 
through the aortic valve and not a hollow conduit. 
purpose of this research was to design a cannula which passes through the aortic valve.  
In use, the cross-sectional area will be a conduit for blood moving from the ou
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2.2.2 Cannulae Placement 
The cannulae were held in place using a threaded rod passing through a port in 
the flow loop (noted ‘Cannula Holder’ in Figure 8).  The rod was turned clockwise to 
push the cannulae through the aortic valve and then adjusted to the correct angular 
position.  The original setup was designed to hold the cannulae in the center of the 
aortic valve but due to the effects of gravity, this goal was not achieved in all tests.  
Although the cannulae were not positioned in the center of the valve while at rest, the 
valve would push the cannulae to center during the closing and subsequent sealing of 
the valve.  This phenomenon is discussed in section 4.2.1.  
The triangular geometry was tested in two positions, one (referred to as the 
Equilateral Triangle) with the corners of the triangle aligned with the commissures of the 
valve and another, (referred to as the Tri-Offset position), where the corners of the 
triangle are aligned with the nodules of the valve leaflets. 
2.2.3 Cannulae Fabrication 
Of the three geometries, the occluded leaflet and equilateral triangular 
geometries were molded for this study (Figure 9 and Figure 10).  The circular geometry 
was made from an undersized half-inch (0.485”) rubber cord o-ring stock.   
Figure 8 - Close up of Experimental Flow Loop Detailing Cannula Placement 
14 CEZO 
 
The mold was machined into two LDPE blocks.  The mold consists of two mating 
halves and four alignment holes.  The channel used to make the equilateral triangular 
cannulae was made using a 5/8” 60° chamfered end mill.  The other channel was made 
using a custom made 1” 120° chamfered end mill.  On the opposite half of the mold, a 
7/8” ball end mill was used to make a semicircular channel to align with the 120° 
triangular channel.  These two sides combine to create the occluded leaflet cannulae.   
Figure 9 - Triangular Cannula 
Figure 10 - Occluded Valve Leaflet Cannula 
 Aortic Valve Performance with Transaortic Ventricular Cannula 15 
 
The cannulae cross-sections were molded using RTV11 two part silicone 
(Momentive, Albany, NY).  The material was selected for its curing time (24 hours), work 
time (1.5 hours), and elasticity (used to dampen vibration in electronics and comparable 
to silicone rubber).  The silicone was prepared by mixing 225 g of silicone with 1.125 g 
of the curing agent for 2 minutes.  The silicone mixture was then placed in a vacuum 
chamber and degassed for 30 minutes under 25 mmHg of vacuum.  The molds were 
prepared by applying a spray-on PTFE mold release coating to both sides of the mold 
(The Sherwin-Williams Company, Cleveland, OH).  Guide pins were inserted on one 
side of the mold and paper plugs were taped in place at one end of the mold channel.  
This was to ensure that silicone did not leak out of the mold during the 48 hour cure.  
The silicone mixture was then drawn into a 140 mL syringe and injected into the 
channel of the mold while it lay horizontal on the table.  The silicone was injected until it 
was level with the top of the channel.  The second side of the mold was then placed on 
top and aligned using the guide pins.  The mold was clamped using 3” C-Clamps and 
placed upright, so that the channels were vertical.  The silicone was allowed to settle 
and a 12” brass rod was used to coax air bubbles to the surface. The mold was then 
topped off using the syringe.  An 8” section of 6-32 threaded steel rod with two nuts was 
imbedded 4” into the top end of the mold. The rod was held in place using washers on 
the top end of the mold.  The threaded 6-32 rod was used to hold, position, and ensure 
proper orientation of the cannulae in the flow loop.  The mold was then allowed to cure 
for 48 hours at room temperature.  
To remove the finished cannulae, the guide pins were removed and the two 
halves of the mold are separated.  The cannulae were peeled from the mold and the 
flashing and paper plug are removed with a razor.  The molds are then cleaned and 
ready to mold another set of cannulae. 
The circular geometry was made using silicone rubber cord stock, which is 
comparable to the RTV11 silicone.  One end of the cord was drilled and tapped to 
accommodate a 6-32 threaded rod.  The threaded 6-32 rod was used to hold, position, 
and ensure proper orientation of the cannulae in the flow loop. 
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2.3  Experimental Rig Design 
2.3.1 Flow Loop 
A flow loop was constructed to mimic physiological flow conditions found in the 
body (Figure 11).  The loop was designed to produce an average flow rate of 6.4 L/min 
and an aortic differential pressure of 90 mmHg.  The flow loop used the Utah Artificial 
Heart Institute’s Ventricle Simulator to drive the flow.  National Instruments Labview 
software and a USB DAQ were used to trigger the ventricular simulator and to record 
the flow rate and differential pressure data. 
The rest of the flow loop was constructed using Tygon tubing with PVC fittings 
and valves.  Since it is a low pressure system the tubing was sufficiently rigid to contain 
the flow.  A pressure transducer (not shown in Figure 11) was used to measure the 
differential pressure across the aortic valve.  An ultrasonic flow meter was connected to 
the return side of the flow loop in order to measure the flow rate of the loop. 
Figure 11 - Experimental Flow Loop Schematic 
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2.3.2 Blood Flow Loop 
The flow loop used for the whole blood hemolysis testing was altered to reduce 
overall volume and the number of parts contacting the blood.  The main modifications 
were to reduce the size of the reservoir from 1.5 liter to 500 mL and to eliminate the 
section of the flow loop which housed the glass viewing port.    
Bovine blood was used for the hemolysis tests and was obtained from Joe’s 
Meat Market in Ontario, NY.  The blood was harvested from calves immediately after 
slaughter according to standard practice for evaluation of cardiovascular devices  
(Kitchen, Olson and Preston).  The blood was mixed with a 3.2% sodium citrate 
aqueous solution in a ratio of ten parts to one.  Sodium citrate helps preserve the blood 
and acts as an anticoagulant.  The blood was stored at a temperature of 2-4° Celsius 
until used in the flow loop.  All blood was used within 72 hours of harvest. 
2.3.3 Flow Visualization 
Downstream from the valve, a glass ‘viewing port was constructed to enable 
high-speed imaging of the valve.  The ‘aorta’ and ‘ventricle’ section of the flow loop were 
constructed of cast acrylic in order to facilitate the use of external lighting of the aortic 
valve and cannulae.  Additionally, high intensity white LED’s were inserted into the 
‘ventricle’ side of the flow loop to backlight the valve and provide sufficient illumination 
for the high speed cinematography. 
2.3.4 Pneumatic Ventricle Simulator 
The Pneumatic Ventricular Simulator (PVS) is a clear plastic mock ventricle constructed 
to mimic the pulsatile contraction of the left ventricle (Figure 12).  The PVS contains one 
inlet with a two leaf mechanical ‘mitral’ valve and two outlets.  The lower outlet, located 
at the base of the ventricle, serves as the connection for the inlet cannula of a VAD. The 
lower outlet was sealed off with a rubber stop cock for this study.  The upper outlet 
contains a two leaf mechanical ‘aortic’ valve which was mechanically fixed in the open 
position by placing a piece of Tygon tubing in the valve to obstruct it.  This was to allow 
the natural porcine aortic valve to behave properly. 
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The ventricle’s contraction (systole) and expansion (diastole) were controlled by 
the Utah Artificial Heart Institute’s Ventricle Simulator.  The Simulator switched between 
a pressure line and vacuum line to contract and expand the ventricle.  The positive 
pressure was provided by a shop compressor and regulated to 350 mmHg.  The 
vacuum was provided by a Fischer LAV-3 vacuum pump providing 25 mmHg of 
vacuum.  The pressures were switched using a fast acting solenoid valve run via the 
analog output on the National Instruments USB DAQ 6008 controlled by National 
Instruments Labview software.  The user interface and block diagram can be seen in 
Appendix C: Labview User Interfaces and Block Diagrams. 
The software created a low frequency square wave (1 Hz) with variable duty 
cycle to control the Driver.  The tests were all run at 60 beats per minute (1 Hz) with the 
systolic phase lasting for 40% of each cycle.  These parameters resulted in the PVS 
Figure 12 - Mock Ventricle used with Pneumatic Ventricle Simulator 
 Aortic Valve Performance with Transaortic Ventricular Cannula 19 
 
providing 90 mmHg pressure differential across the aortic valve and a mean flow rate of 
6.4 L/min.  These adequately mimicked physiological values for pressure and flow.  
2.3.5 Data Acquisition 
The signals from the pressure and flow rate sensors were collected using 
National Instruments USB DAQ 6008 along with National Instruments Labview software.  
The differential pressure and flow rate data was collected at 100 samples per second 
for a 10 second period.  The data was written to a file and imported to Microsoft Excel 
for post processing.  The user interface and block diagram can be seen in Appendix C: 
Labview User Interfaces and Block Diagrams.   
2.3.6 Camera Triggering 
High speed videos were taken using an IDT MotionPro X3 Plus High Speed 
Digital Camera with IDT Motion Studio v 2.07.12 software.  The camera was synced to 
the flow loop using a five volt analog output trigger from the NI USB DAQ 6008.  The 
camera software was set to begin at the detection of the first rise in voltage output, 
which corresponded to the first contraction of the ventricle.  The camera then captured 2 
seconds of footage at a rate of 60 frames per second, to ensure that two complete 
cardiac cycles were present in each video sequence. 
2.4 Valve Sourcing and Fixturing 
2.4.1 Preliminary Valve Study 
A sheep heart was obtained from a local butcher to conduct preliminary 
observations and to determine the best methods for removing the aortic valve from the 
heart and fixturing the aortic valve during experimentation.  Following these preliminary 
observations, it was determined that the best way to fixture the valves was to suture the 
valve to a felt ring and then mechanically hold the felt in the flow loop.  This method 
enabled the valve to be held in a natural orientation, prevented flow from leaking around 
the outside of the valve, and evenly distributed the holding force around the valve 
(Figure 13).   
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2.4.2 Valve Source 
The aortic valves used during testing were taken from healthy adult pigs.  The 
porcine hearts were ordered from ASTCO, Incorporated, El Paso, TX. The hearts 
arrived in a Styrofoam container filled with ice and were kept between 2-4° Celsius.  The 
valves had an approximate life of two weeks before the tissue degraded to the point 
where it no longer functioned like a freshly explanted valve.  
2.4.3 Valve Removal 
In order to isolate and separate the aortic valve from the rest of the cardiac 
tissue, a dissection was performed.  A detailed procedure for removing the aortic valve 
can be found in Appendix A: Aortic Valve Dissection.  The aortic valve was carefully 
removed from the heart and rinsed in 0.9% phosphate buffered saline (PBS).  The 
coronary arteries, which attach to the sinus of valsalva, were sutured shut in order to 
prevent fluid from leaking around the aortic valve (Marieb and Hoehn).  This does not 
affect the function of the aortic valve since the flow to the coronaries is insignificant 
compared to the mean flow through the aortic valve.   
2.4.4 Valve Fixturing 
The aortic valve was then sutured to felt rings.  Felt was used to fix the valves in 
the flow since it is easily penetrated with sutures, slightly deformable to the aortic tissue, 
resistant to tearing, and mechanically strong enough to hold the valve in the flow.  The 
sutures used were Ti-Cron coated, braided, polyester, non-absorbable sutures with a 
size 0 general surgery half circle tapered needle (Esutures, Mokena, IL).  Using the 
sutures, the one inch internal diameter by two inch outer diameter by quarter inch thick 
felt washers were sutured to the valve using simple running stitches (Bell and Bell).  The 
stitches were tied off and glued to the felt ring with Loctite 404 cyanoacrylic adhesive to 
ensure that the sutures would not slip. 
The ventricle side felt ring was sutured to the aortic valve annulus.  The aorta 
side felt ring was sutured to the sinotubular junction (Figure 13) and the coronary 
arteries sutured shut.  To maintain the original length of the aortic valve, a 1.5 inch 
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diameter PVC pipe spacer was cut to length and inserted between the felt rings.  
Finally, to provide a surface to seal the aortic valve in the flow loop, a 2 inch diameter 
PVC pipe spacer was cut to length and completely covers the OD of the aortic valve/felt 
ring assembly for the entire length.  The aortic valve assembly was stored in PBS until it 
was needed for testing. 
2.4.5 Valve Preservation 
In order to prolong the life of the aortic valve, the valve was preserved in a 
solution consisting of 0.9% Phosphate Buffered Saline and 0.2% Gluteraldehyde.  
Additionally, the valves were stored at 2-4° Celsius which kept the valve useable for up 
to fourteen days. 
Figure 13 - Aortic Valve Assembly 
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2.5 Measurements – Specific Methods 
2.5.1 Spectrophotometer 
The Genesys 10uv Spectrophotometer uses a single beam of visible light and a 
photo detector to determine the absorbance of a sample.  A single wavelength beam is 
created by taking a collimated white light source and reflecting it off a diffraction grating 
in order to separate the light into its respective wavelengths, much like a prism.  Then 
the separated light passes through an aperture that isolates a specific wavelength.  The 
light then passes through the sample and the remaining light is detected by a photo 
detector.  The photo detector translates the light into an electrical current via the 
photoelectric effect.  This current is then used to determine the amount of light absorbed 
by the sample.   
2.5.2 Plasma-free Hemoglobin Concentration  
The concentration of PfHb was measured using the Cyanmethemoglobin method  
(Malinauskas).  The process involves mixing the separated plasma from the blood 
sample with a chemical reagent which binds to all hemoglobin present in the sample.  
The resulting compound is cyanmethemoglobin which absorbs at specific wavelengths 
of light.  Using a Spectrophotometer, the samples were measured for their absorbance 
at a wavelength of 540 nm (Amatuzio, Grande and Wada) (Balasubramaniam and 
Malathi). 
In order to separate the plasma from the whole blood sample, the blood was 
spun in a centrifuge for 10 minutes at 3,500 RPM’s.  The plasma was drawn off the top 
with a pipette, and spun a second time at 15 minutes at 10,000 RPM’s.  This ensures 
that all red and white blood cells are removed from the plasma.   
The chemical reagent used for the Cyanmethemoglobin method is called 
Drabkin’s Reagent (Table 1).  The two cyanide compounds react with the hemoglobin to 
produce cyanmethemoglobin.  
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Compound Quantity 
Potassium Ferricyanide 400 mg 
Potassium Dihydrogen Phosphate 280 mg 
Potassium Cyanide 100 mg 
Nonidet 1 mL 
Distilled Water 1 L 
 
Table 1 - Drabkin's Reagent Formula 
2.5.3 Hemolysis 
Following the aortic insufficiency test, a hemolysis study was conducted on the 
circular and equilateral triangular cross sections, both of which demonstrated very low 
levels of aortic insufficiency.  A test was run with the ventricular simulator in a simple 
flow loop in order to obtain a baseline measurement of the hemolysis caused by the 
pump.   
A whole blood experiment, the most direct method for determining the cannula’s 
effect on blood, was performed to test the DBC’s induced hemolysis.  The experimental 
set up was run with whole blood as the working fluid and the obstruction in place.  The 
outflow cannula’s induced hemolysis was measured by comparing these results to the 
baseline tests.  Hemolysis was measured using the Cyanmethemoglobin method. 
The induced hemolysis rates are then used to calculate the Normalized Index of 
Hemolysis (NIH).  The NIH is a metric used in hematology research to equate in vitro 
and in vivo blood testing.  NIH is measured in grams per 100 liters and the calculation is 
shown in Equation 1, where ∆
 is the increase in plasma free hemoglobin, V is the 
overall volume of the flow loop,  is the percent hematocrit of the whole blood, Q is 
the volumetric flow rate, and t is time in which the test was performed. 
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Equation 1 - Normalized Index of Hemolysis 
 =  ∆
 ∙  100 − 100  100 ∙  
2.5.4 Differential Pressure 
The differential pressure was compared between the three geometries and the 
control case.  The peak systolic differential pressure was averaged over ten cardiac 
cycles for each geometry and compared with the hydraulic diameter and the area open 
to flow.  Also, the peak systolic differential pressure was used to determine the pressure 
loss coefficient across the aortic valve.  The hydraulic diameter (DH) was calculated for 
the aortic valve with each cannula in place using Equation 2 and Figure 14. 
Equation 2 - Hydraulic Diameter 
 
~  
!" 
 =  # (%&'()* + ,-.//01.)3'()4 567896:67-.//01. 
Figure 14 - Definition of Hydraulic Diameter Variables 
Adapted from (Art) 
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The area and perimeters of the cannulae were calculated using their respective 
equations (Fox, McDonald and Pritchard).  The pressure loss coefficient (k) was 
calculated using the relationships in Equation 3  (Fox, McDonald and Pritchard). 
Equation 3 - Pressure Loss Coefficient 
∆
 ~ ; <<  ~ ; 
<
<  ~ ; 
<
#  
Additionally, the pressure taps were used to prove that the flow loop mimicked 
physiological flow through the aortic valves used in this study.  The taps were passed 
through the felt rings of the aortic valve assembly and opened at the edge of the tissue 
on the inside of the aortic valve. This allowed the direct differential pressure across the 
valve to be measured during all experiments.  The pressure taps were constructed of 
316 stainless steel 16 Gauge hypodermic tubing and were connected to a Validyne 
DP15 variable reluctance pressure transducer via 1/16” ID Tygon tubing.  The 
transducer was run using a Validyne CD15 Carrier Demodulator which was calibrated to 
18.98 mmHg/V. 
2.5.5 Flow Rate 
The Ultrasonic Flow meters use the Doppler Effect to determine fluid speed non-
invasively.  By knowing the cross-sectional area of the tubing in which the sensor is 
attached, the volumetric flow rate can be determined. 
Flow rates were measured using an em-Tec Ultrasonic clamp-on flow meter.  
The flow meter was mounted to the reservoir return tube located between the aorta side 
of the aortic valve and the reservoir.  The flow meter was calibrated for use with 1/2” by 
3/32” wall thickness Tygon tubing.  The Ultrasonic flow meter was run using the em-Tec 
DigiFlow controller and had an output of 0.25 V/(L/min). 
2.5.6 Aortic Insufficiency 
For this study, the AI was compared for the three cross-sectional geometries and 
the control experiment over ten cardiac cycles.  Five different diastole experiments were 
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performed in order to test three basic geometries, the Equilateral Triangular geometry in 
an offset orientation, and a no obstruction case.  An aortic valve with no obstruction was 
tested as a control and the results were used as a baseline reading for aortic 
insufficiency.  It was predicted that a healthy valve would exhibit 0% AI (Bonow and 
Nishimura).  After the baseline test, the three cross sectional geometries were fed 
through the aortic valve and AI analyzed.  The AI was also compared with the resulting 
hydraulic diameter of the aortic valve with the cannulae passing through it. 
AI is the ratio of the volume regurgitated during diastole to the volume ejected 
during systole and was measured in this study by integrating the flow rate data over 
time (Equation 4).  Therefore the flow rate data was integrated using the trapezoidal 
method over the systolic and diastolic portions of the cardiac cycle to obtain the 
respective volumes (V). 
Equation 4 - Aortic Insufficiency Definition 
 =  =6>?7>8:@:6ABC6D:6A  
2.5.7 High Speed Cinematography 
Another notable feature of diastole that was examined was the dynamics of the 
valve closing and consequently sealing against an obstruction.  The high speed 
cinematography was used to witness which features of the valve and obstruction 
geometry are important for mating and sealing.  The dynamics of the valve sealing were 
examined using high speed cinematography. 
This is a qualitative measurement rather than quantitative since it was not initially 
clear which aspects were important in sealing.  Some aspects considered are the time 
to seal, leaflet overlap, and leaflet collapse.  To perform the dynamic observations, high 
speed camera equipment was mounted to view the valve from a downstream position, 
looking at both the cannula and valve from the aorta side of the flow loop.   
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2.6 Measurement Calibration 
2.6.1 Spectrophotometer 
The spectrophotometer was calibrated to ensure the machine was functioning 
properly.  The machine was set to measure absorbance at 540 nm.  In order to set the 
zero absorbance of the spectrophotometer, 2 mL of Drabkin’s reagent were mixed with 
1 mL of distilled water.  This mixture was pipetted into a cuvette and placed in the 
spectrophotometer.  The corresponding absorbance was set as the blank absorbance 
(absorbance read 0.000 A).  A detailed setup procedure for the spectrophotometer can 
be found in Appendix B: Spectrophotometer Setup. 
2.6.2 Plasma Free Hemoglobin 
In order to determine the percentage of PfHb in the blood samples taken during 
the hemolysis testing, the total hemoglobin present in the whole citrate bovine blood 
was first determined. 
Table 2 details the mixtures used to calibrate the absorbance of a sample to the 
percentage of Hemoglobin present in the sample. 
Percent Total Hemoglobin Preparations 
Hemoglobin Percentage 0.0% 2.5% 5.0% 7.5% 10.0% 15.0% 
Whole Blood Sample (μL) 0 25 50 75 100 150 
Distilled Water (μL) 1000 975 950 925 900 850 
 
Table 2 - Hemoglobin Control Preparations 
These preparations were then mixed with 2 mL of Drabkin’s reagent in plastic 
cuvettes.  Five replicates of each concentration were prepared.  These were then 
analyzed in the spectrophotometer.  The results can be seen in Figure 16, except for 
the valves pertaining to the 15% Hemoglobin samples, as they were out of the 
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absorbance range for the spectrophotometer.  The spectrophotometer output was ‘>3 
Out of photometric range’ for all five readings and are therefore not included in the 
graph. 
In order to correlate the percent total hemoglobin to a concentration of 
hemoglobin, the absorbance of different hemoglobin concentrations was determined.  
This was accomplished by taking Powdered Bovine Hemoglobin and creating several 
solutions of differing concentrations.  One milliliter of these concentrations was then 
mixed with 2 mL of Drabkin’s Reagent in plastic cuvettes.  The different samples were 
then measured for absorbance in the Spectrophotometer.  The results are displayed in 
Figure 15, where the relationship between absorbance of the mixtures and hemoglobin 
concentration is a linear relationship with a slope of 3.56 Absorbance per g/dL. 
Using the relationship between absorbance and hemoglobin concentration, the 
total hemoglobin concentration of the citrated bovine blood can be determined.  Since 
the same batch of citrated bovine blood was used for the duration of all hemolysis 
testing, the total hemoglobin concentration for all tests was 20 g/dL, which is within 
normal natural values for bovine blood. 
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2.6.3 Pressure Transducer 
 The Validyne DP15 Variable Reluctance Differential Pressure Transducer 
was calibrated using a variable height manometer made of 1/16” Tygon tubing and a 
polycarbonate 125 mL reservoir.  The resulting voltage output versus pressure can be 
found in Figure 17, with a slope of 18.98 mmHg/V. 
2.6.4 Ultrasonic Flow Meter 
The em-Tec Ultrasonic Flow Meter was calibrated by running a pump and 
reservoir in a closed loop.  The flow meter was clamped on the outflow side of the loop.  
The pump was run at a constant speed and the outflow collected in a graduated vessel 
for a specific amount of time.  Data from the flow meter was collected during this test 
and averaged over the time of collection to determine the calibration of the flow meter in 
V/(L/min).  The resulting calibration was 0.25 V/(L/min), which is consistent with the 
initial calibration of the instrument approximately one year prior to this calibration.   
 
Figure 17 - Pressure Transducer Calibration 
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2.7   Experiment Validation 
2.7.1 Pressure 
The flow loop was tested in order to determine if physiologically accurate 
pressures were being produced by the PVS.  The flow loop was run with saline as the 
working fluid, an aortic valve in place, and no cannulae present in the flow.  The 
differential pressure between the ‘ventricle’ and ‘aorta’ sections of the flow loop was 
measured to validate that physiological conditions had been met.  The peak systolic and 
diastolic pressures do correspond to physiological conditions, but there is a second 
order under damped response to sudden changes in pressure.  The second order 
response is not seen physiologically, and therefore the flow loop was analyzed to 
determine the source.  Several features of the flow loop were suspected to cause the 
response, with the most likely source being the pressure transducers themselves. 
The pressure taps and transducer can be modeled as an RLC circuit and are 
subject to the same governing equations (Aerts, Carbonaro and Van den 
Braembussche, Chapter III - Pressure Measurments).  An RLC circuit is an electrical 
circuit consisting of a resistor (R), inductor (L), and capacitor (C) with a time dependant 
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Figure 18 - Experimental Underdamped Second Order Response 
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current (I(t)).  The flow through the pressure taps and transducer can be modeled as an 
RLC electrical circuit with the fluid inertia analogous to the inductance of the circuit, the 
viscous losses through the pressure tap acting as resistance of the circuit, the change in 
volume of the transducer behaving like capacitance, and the volumetric flow rate (Q) 
being the equivalent to electrical current.   
Equation 5 - RLC Circuit 2nd Order ODE with Fluid Analogy 
E << +  G  + H = 0 
E = 4 J KL< 
GM@98N@7 = 128 Q KL# 
HRNDS9T76UU8VW6 =  
 
 =  
The derivations of these terms can be found in Appendix D: Pressure Transducer 
Analysis.  Looking at the graph of a second order system we can see that it is under 
damped due to the sinusoidal response (Figure 19).  For the purposes of this study, the 
information which is important in this system is the settling time (ts).  The settling time is 
how long it takes an under damped system to reach a certain tolerance of its final value 
and stay between those margins (Figure 19).  The settling time of the second order 
system is defined in Equation 6 and is a function of the natural frequency (ωn), the 
damping coefficient (ζ), and the tolerance interval.   
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Equation 
Using the formula for settling time along with the fluid analogies for an
circuit we can define ωn, ζ, and t
Chapter III - Pressure Measurments)
Figure 19 - Settling Time of an Under Damped Second Order System
6 - Settling Time for an RLC circuit 
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settling time for the pressure taps and transducer system is 0.47 seconds.  The 
experimental pressure transducer data from the flow loop (Figure 20), shows a similar 
settling time (~0.4 seconds). 
Equation 7 - Settling Time for Pressure Tap and Transducer 
U  2 LR ln$XK Y !YZ K2 
 U   <16 a  ln$XK Y !YZ K2 
Since the settling time of the pressure tap and transducer closely match the 
settling time found experimentally, it is concluded that this is the source of the second 
order response.  This means that the pressure oscillations following sudden changes in 
pressure is not present in the flow loop and is only an artifact of the measuring 
technique.  However, it is difficult to say for certain considering the many assumptions 
made to analyze the pressure transducer system.  One of the assumptions is that the 
flow in the pressure taps and transducer is defined as a linear second order system.  In 
reality it is a non linear system since the resistance of the system is a function of the 
fluid velocity.  Additionally, the flow in the pressure tap is assumed to be laminar.  The 
RLC circuit model does not take into account the elasticity nor the movement of the 
pressure tap.  Finally, the time settling equation is defined for a step in pressure, but the 
experimental pressure is not purely a step but rather a sudden rise or drop in pressure 
over a very short amount of time in comparison to the settling time. 
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2.7.2 Flow Rate 
The flow loop was tested in order to determine if physiological flow rates were 
being produced by the PVS.  The flow loop was run with saline as the working fluid, an 
aortic valve in place, and no cannulae present in the flow.  The transient flow rate was 
measured on the ‘aorta’ section of the flow loop.  The output from the flow meter was 
monitored for 10 cardiac cycles and averaged over that time.  The flow rate or Cardiac 
Output (CO) of the PVS was 6.4 L/min, which is an acceptable value for a patient with 
an LVAD implanted.   
2.7.3 Aortic Insufficiency  
The flow loop was validated for both the AI and hemolysis measurements.  The 
control for the AI measurement was to use the flow loop with an aortic valve and no 
cannula.  The resulting AI was 2.4% with a standard deviation of 0.00941 over 10 
measurements in each of two trials (Figure 21).  This amount of AI is insignificant and 
virtually undetectable clinically.  This validates that the valves used in this experiment 
were functioning properly.  Additionally, the pressure and flow rate curves for the flow 
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An aortic valve without cannulae was used to obtain this Pressure and Flow rate. 
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loop are indeed within physiological parameters.  This validates that the PVS functioned 
properly and that the flow loop did not add additional dynamics to the flow.  
2.7.4 Hemolysis 
In order to quantify the amount of hemolysis caused by the flow loop and PVS, 
two control tests were performed.  First, a simple loop
loop to a reservoir was used to quantify the amount of damage caused by the PVS.  It 
was thought that the mechanical valves in the PVS could cause a significant amount of 
hemolysis, since mechanical aortic valve prostheses have been shown 
hemolysis.  The results of this test were that the hemolysis was around 
minutes of testing.  This low level of hemolysis made the PVS an adequate pump to use 
for the remainder of blood testing. 
The next hemolysis control was done w
fluid in a test loop with an aortic valve in place, but no cannulae.  This test was meant to 
show that the additional components in the flow loop and the porcine valve would 
contribute an insignificant amount of hemoly
after 10 minutes with the final PfHb level at 
blood.  The test was stopped due to a leak in the flow loop.  Although the cause of the 
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leak was not definitively determined, there are a couple suspects.  Upon draining the 
loop, two large thrombi were discovered.  One was found in the PVS and the other 
attached to the felt downstream of the aortic valve.  It is possible that the clot got 
pushed through the aortic valve during diastole and obstructed blood from flowing 
through the valve.  This in turn increased the ventricular pressure to the point that blood 
was able to leak out of the flow loop.  Due to a limited supply of whole bovine blood for 
the testing, this test could not be repeated, but based on the subsequent tests we can 
infer that the amount of hemolysis contributed by the flow loop and aortic valve are 
insignificant. 
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3. Results 
 
3.1 Aortic Insufficiency 
The comparison of aortic insufficiency is found in Figure 22, which shows the 
mean aortic insufficiency with standard deviation.  The circular geometry exhibited the 
least amount of aortic insufficiency, although all the geometries exhibited AI less than 
30% and are therefore classified as Mild AI according to the AHA (Bonow and 
Nishimura). 
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Figure 22 - Aortic Insufficiency of tested geometries 
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The circular geometry demonstrated the lowest AI of all geometries at 7.1% AI 
and was the most consistent of all experiments with a standard deviation of 0.00434.  
The Equilateral Triangular cross section had an AI of 12.7% with a standard deviation of 
0.0255, which was the largest deviation of all the geometries experimented.  The 
Triangular Offset test had the largest average AI at 15.1% AI and a standard deviation 
of 0.00854.  Finally, the Occluded Valve Leaflet cross section caused an AI of 13.0% 
and a standard deviation of 0.0135.  
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Figure 23 - Aortic Insufficiency versus Hydraulic Diameter 
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The AI was also compared as a function of hydraulic diameter (Figure 23 and 
Table 3).  The data points include all the cannulae geometries and the control case.  
The control exhibits the least amount of AI and has the largest DH. 
Table 3 - Hydraulic Diameter and Area of Cannulae 
 
Control Circular Triangular Tri-Offset Occluded 
Hydraulic Diameter (in) 0.822 0.337 0.253 0.253 0.556 
Area Open to Flow (in2) 0.531 0.346 0.380 0.380 0.352 
 
3.2 High Speed Cinematography 
Through examining the video of the aortic valve closing, the dynamics of the 
aortic valve were able to be determined.  Several phenomena were noticed when the 
cannulae were present in the valve that did not occur during the control experiment.  
Following are sample film strips from the experiments.  Due to the perspective of the 
footage, the cannulae appear larger than they actually are. 
Figure 24 - Diagram of Key Features. 
A) Tubing viewed from downstream; B) Felt Ring; C) Aortic Wall; D) Aortic Valve Leaflet, either 
closed or open depending on phase of cardiac cycle; E) Cannula Cross Section. 
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Although the circular cross section does perform the best in terms of AI, there are 
several phenomena noticed in the high speed video which show that the valve has 
issues conforming to the circular geometry.  There is excessive bunching and folding of 
the valve which is discussed in section 4.2.2.  
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Figure 25 - Aortic Valve Sealing 
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Figure 26 - Aortic Valve Sealing Around Circular Cannula 
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Figure 27 - Aortic Valve Sealing Around Equilateral Triangular Cannula 
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Figure 28 - Aortic Valve Sealing Around Equilateral Triangular Cannula (Offset Position) 
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Figure 29 - Aortic Valve Sealing Around Occluded Leaflet Cannula 
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3.3 Hemolysis  
 Hemolysis was measured for the triangular and circular cross section, as well as 
the control tests.  The results indicate that negligible amounts of hemolysis occurred 
during all four tests run using whole citrated blood. 
Of the two control tests, the aortic valve control test experienced the largest 
amount of hemolysis with 0.53% PfHb present in the blood after ten minutes of testing.  
This test was stopped due to complications discussed in section 2.4.7.  The Ventricular 
Simulator control produced 0.46% PfHb after sixty minutes of testing. 
The two cross sectional geometries tested exhibited low rates of hemolysis.  Both 
geometries produced 0.49% PfHb after sixty minutes of continuous running of the flow 
loop. 
Additonally, the NIH was calculated for each of the tests.  The rate of PfHb and 
the resulting NIH for each hemolysis test are listed in Table 4.   
Table 4 - Normalized Index of Hemolysis Results 
Trial ∆
/ NIH 
Ventricular Simulator Control 9.20E-06 0.017 
Triangular Cannula 4.69E-06 0.009 
Circular Cannula 1.99E-06 0.004 
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3.4 Pressure 
The peak systolic differential pressure across the aortic valve was measured for 
each of the three geometries and the no cannula control case.  The pressure data was 
plotted against the hydraulic diameter (Figure 32) and the area open to flow (Figure 31).  
Additionally, the pressure data, hydraulic diameter, and area open to flow were used to 
calculate the coefficient of pressure loss across the aortic valve (Figure 34 and Figure 
33).  
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Figure 30- Hemolysis Test results for several geometries and control tests 
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Figure 31 - Differential Pressure versus area open to flow 
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Figure 34 - Coefficient of Pressure Loss (Hydraulic Diameter) 
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3.5 Error and Uncertainty Analysis 
Error and uncertainty are inherent to any investigation where physical 
measurements are taken.  Although error and uncertainty are unavoidable, they can be 
mitigated by design of the experiment or accounted for in the data analysis.  Error can 
be broken down into two types, random and bias.  Uncertainty, in its many forms, can 
be calculated and includes everything from human error and accuracy of measurement 
instruments (Aerts). 
3.5.1 Random Error 
When measurements of the same item are repeated, the difference between 
these measurements and the mean of the measurements is the random error.  All the 
measurements in this study are subject to random errors, but the effects of this error on 
the results can be limited.   
For instance, the measurement for AI uses two techniques to mitigate this type of 
error.  The AI measurement is calculated from the flow rate measurement over time.  By 
integrating the flow rate over a long period of time, the random errors due to the flow 
rate measurement are eliminated.  This is due to the fact that random error is both 
positive and negative to the actual value.  Therefore, by summing (or integrating) a 
large number of measurements, the positive and negative random errors will cancel 
each other.  This is good for reducing random error from the sensor, but due to the 
experimental setup, there is still random error associated in the actual flow rate itself.  In 
order to quantify this random error, AI was calculated for several cardiac cycles at the 
same PVS parameters.  The random error in this case is quantified by taking the 
standard deviation of the duplicated measurements (Aerts). 
3.5.2 Bias Error 
Bias error occurs when there is a constant difference between the mean 
measured value and the actual value.  This type of error can be accounted for and the 
data adjusted to reflect the actual value (Fox, McDonald and Pritchard).   
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An example of bias error in this study is the data acquisition.  The USB DAQ 
used to collect the pressure and flow rate over time has a constant voltage bias.  The 
bias was measured and subtracted from all subsequent data to ensure that the 
collected data points reflected the actual output of the sensors. 
3.5.3 Uncertainty 
The estimated variation of a measurement is known as uncertainty.  Uncertainty 
of a measurement is function of the precision of the measuring instrument and the 
manner in which the instrument is operated.  Uncertainty can also be determined for 
calculated values. 
The uncertainty of a measurement such as hemolysis, accounts for several 
sources of uncertainty.  The resulting hemolysis percentage versus absorbance found in 
Figure 16 has variation due to the precision of the pipettes, the spectrophotometer, and 
person using the equipment.  The experimental data was fit to a curve using the least-
squares method (Equation 8) in Microsoft Office Excel 2007.  The resulting linear fit of 
the data was used to determine the percent hemolysis found in each sample during the 
hemolysis testing.  Therefore the variability or uncertainty of each point on the line 
needed to be determined.  In order to accurately determine the variability of each point 
on the linear fit, the standard error of the least-squares was calculated using Equation 9 
(Beckwith, Marangoni and Lienhard V). 
Equation 8 - Sum of Squares 
c< =  def8 −  f(g8)h<
N
8ij
 
Equation 9 – Standard Error of Least-Squares Fit 
  =  ] c<Y − 2 
54 CEZO 
 
Equation 10 - Uncertainty of Hemolysis Measurement 
k69SWU8U =   % "XKf! 
From the standard error, the uncertainty can be calculated for each point using 
Equation 10 (Beckwith, Marangoni and Lienhard V).  The resulting quantity for the 
standard error of the least-squares fit corresponds to ±0.25% hemolysis.  Therefore, the 
uncertainty at a measured value of 0.38% hemolysis, is ±67% of the hemolysis value.  
This is the largest uncertainty of all the measured values since it corresponds to the 
lowest measurement of hemolysis.   
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4. Discussion 
  
4.1 Aortic Insufficiency 
The results from the AI measurement indicate that while the shapes do produce 
a consistent and measureable amount of AI, it is well below AHA recommendations for 
intervention.  The AHA rates AI from 0-30% as mild, and only suggests using 
medication or a change in diet if you are at the upper end of that scale.  From 30-50% 
AI the AHA classifies the AI as Moderate and recommends a regimen of medication and 
a change in diet to control and lower the AI.  With more than 50% AI, labeled as Severe 
AI, the AHA recommends a valve replacement along with medication and diet change.  
The method of intervention used is on a patient to patient basis and the AHA AI metrics 
are merely a guideline for physicians (Bonow and Nishimura).   
Even though the AI caused by the cannulae are low, they are not necessarily 
indicative of the AI the cannulae would cause in vivo, especially with diseased valves or 
hearts.  The fact that aortic valves used were from healthy pigs means that the valves 
were more pliable and they did not contain fused leaflets or calcification.  The AI was 
merely used as a metric for comparing the effectiveness of the cannulae cross sections.   
Additionally, the effect of VAD support on AI was not considered in this study.  
Although the flow rate through the aortic valve was similar to natural blood flow while on 
VAD support, the pressures were compared to natural physiologic blood flow.  The 
pressure in the ventricle while on VAD support can become low enough to cause 
suction on the ventricle side of the aortic valve.  The effect that this suction has on the 
AI was not determined in this study but could be analyzed in further bench top testing.   
One item noticed is that even when the cannula sections are not perfectly 
positioned, the cannula would move to center during diastole.  This occurred for both 
radial and angular displacements.  Precisely positioning the cannulae during the 
experiments was difficult due to gravity acting on the cannulae and the mechanism used 
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to rotate the cannulae.  Proper position at the start of the tests seemed to have a limited 
effect on the aortic insufficiency with the exception of the Equilateral Triangular cross 
section. 
Triangular cross section aortic insufficiency standard deviation was rather large 
compared to its mean value and to the standard deviation of the other tests.  This can 
be attributed to radial and angular displacement of the cannula.     
The equilateral triangular cannula exhibited two stable positions, one with the 
corners aligned to the aortic valve commissures, and the other with the corners aligned 
with the leaflet nodules.  The latter position was referred to as the triangular offset 
position.  The interesting finding in this position was that the valve would rotate and 
push the cannulae to center even when the corners aligned with the nodules of the 
leaflets.  As expected, this resulted in a larger amount of AI because the leaflets had to 
seal against a sharp corner.  Although it is a more difficult geometry to seal to, the valve 
was still able to adequately seal to the cannula, as indicated by the AI of 15.1%.   
4.2 High Speed Cinematography 
From analyzing the still images of the high speed cinematography, many things 
can be concluded.  The dynamics of the valve sealing against the cannula were 
witnessed as well as several phenomena, such as movement of the cannula, leaflet 
folding, and leaflet twisting.  The valve behaved normally for the control tests and did 
not exhibit any notable behavior. 
4.2.1 Cannulae movement 
As previously mentioned, the cannulae would get pushed to the center of the 
valve during diastole even if the cross section was out of position during systole.  This 
movement would take place during the transitions between diastole and systole and 
only occurred when the circular and triangular geometries were in the flow.  This 
resulted in a slightly longer period of time where the valve was in the act of closing since 
the leaflets were centering the cannula.  This effectively increased the length of the 
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diastolic portion of the cardiac cycle and allowed a longer time during which 
regurgitation could take place.   
The circular geometry experienced a radial displacement, meaning that if the 
cannula was resting against the outer edge of the aortic valve, the leaflets would push 
the cannula to center during the closing of the valve.  This movement can be seen in 
Figure 35, where the cannula moves from left to right over the course of 166 
milliseconds.   
During the triangular geometry tests, both radial and angular displacements were 
noticed when analyzing the high speed cinematography.  This means that not only 
would the valve move to center as it did with the circular geometry, but it would also 
rotate it to a ‘preferred’ position.  It is interesting to note that the valve would rotate the 
cannulae to a ‘preferred’ position even if the original position was off by as much as 15°.   
Figure 35 - Cannula Movement 
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The ‘preferred’ positions refer to the two orientations to which the aortic valve 
would push the cannula repeatedly and consistently.  The first position is when the 
corners of the triangle align with the aortic valve commissures.  The other stable 
position occurred when the corners of the triangular cannula aligned with the leaflet 
nodules and is referred to as the triangular offset position.  This is a little counter 
intuitive since it requires the leaflets to deform around a sharp (60°) corner. 
4.2.2 Valve leaflet deformation 
It was noticed that the valve leaflets themselves were prone to bunching and 
folding due to the presence of the cannulae.  This occurred when a cannula was 
present in the valve, but varied in the severity and repeatability of the deformation.  
Experiments with the circular cannula in place repeatedly demonstrated leaflet 
deformation.  The leaflet would fold and bunch in its effort to conform to the curved 
surface of the cannula while closing against it.  This phenomenon can be seen in the 
still image (Figure 36) taken using high speed cinematography.  
Figure 36 - Leaflet Bunching 
Leaflet edge is highlighted for clarity 
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While the cyclic folding and bunching of the leaflets did not cause any noticeable 
defects during the short in vitro experiments, it could be a source of inflammation and 
tissue degradation in future long term animal model testing.  Since the leaflet 
deformation varies between the geometries and is most pronounced in the circular 
geometry, the long term effects caused by the leaflet deformation could also vary 
between geometries. 
4.2.3 Valve twisting 
Another dynamic noticed from the porthole in the flow loop was valve twisting.  
This occurred in a few experiments and was never recorded by the high speed 
cinematography.  It was observed during preliminary tests while trying to align the valve 
and cannulae.  Although this phenomenon was not present during the testing from 
which the AI was calculated, it is still significant.  The fact that the valve twists shows 
that there is considerable force acting on the valve leaflets.  Not only can the leaflets 
push the cannulae into position but the valve itself can be moved.   
The twisting of the valve was eliminated by tightening the aortic valve assembly 
to the flow loop.  While this proved adequate for in vivo use, the aortic valve may be 
able to move more freely in the body.  Since the aortic valve already moves with the rest 
of the heart during each cardiac cycle, this valve twisting could alter valve dynamics. 
4.3 Hemolysis 
The hemolysis results are promising but inconclusive.  Of the two geometries 
tested, there is no distinguishable difference in the induced hemolysis.  Additionally, the 
total amount of hemolysis is at the lower end of what the designed test is capable of 
measuring.  This fact also attributes to the rather large uncertainty found for the 
hemolysis measurements.  Although the uncertainty ranges from ±50-67% of the 
hemolysis value, the values are still low enough that the hemolysis rates are 
insignificant.  The hemolysis test could be redesigned in order to provide a more precise 
analysis of hemolysis.  The test used in this study was designed to determined 
hemolysis rates between 0 and 10 percent of total hemolysis.  If the test was 
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redesigned to measure hemolysis between 0 and 1 percent hemolysis, the standard 
error would be considerably lower in comparison to measured values.    
The important thing to note about the hemolysis results is that the tests produced 
negligible amounts of damage to the blood cells.  This is important since it shows that 
the valve will comply with the flow and not produce turbulent jets capable of red blood 
cell damage, even when the leaflets of the valve are considerably obstructed compared 
to their natural dynamics. 
4.4 Pressure 
The peak systolic differential pressure results show that the pressure drop is a 
function of the area open to flow but not of the hydraulic diameter.  This is interesting 
since the hydraulic diameter is meant to quantify the effective diameter of non circular 
geometries, by taking into account the wall effects on the pressure loss.   
In order to further analyze the relationship between the peak systolic differential 
pressure, area open to flow, and hydraulic diameter, the coefficient of the pressure loss 
across the aortic valve was calculated using two methods.  First k was determined by 
using the hydraulic diameter and then plotted against the pressure loss.  What is 
interesting is that the resulting graph (Figure 34) demonstrates no functionality between 
hydraulic diameter and pressure loss. Then k was calculated using the area open to 
flow and plotted against the pressure loss.  This time the resulting relationship between 
the area and pressure loss is linear (Figure 33).  This is interesting, although the 
coefficient of pressure loss is technically supposed to be a constant value relating the 
pressure loss, flow rate, and diameter.   
4.5 Cannulae Comparison 
From combining the results of the AI, video, and hemolysis tests, it seems that 
the triangular cross section performed the best within the aortic valve.  This assessment 
is not necessarily conclusive, as there is evidence that the circular and occluded valve 
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cross sections would also be suitable in vivo.  Further testing of these designs could 
better predict which would best work with the aortic valve. 
The geometries were ranked on a scale of 1-3, where the lower the number 
refers to a better performance.  The ranks of each metric were tallied for each cannula, 
revealing the Triangular geometry as the best performing cannula (Table 5). 
Table 5 - Cannulae Comparison 
Metric Circular Triangular Occluded 
AI 1 2 3 
Video 3 1 2 
Pressure 3 1 2 
Hemolysis 1 1 N/A 
Total 8 5 7 
 
4.6 DBC’s Use In Vivo 
The results of this study are promising but leave many questions to be resolved 
upon further testing of the DBC.  The practicality of the DBC has been proven for at 
least the short term, but further testing and design is needed to bring the idea through to 
fruition.  
4.6.1 Materials 
The RTV11 Silicone used during this experimentation may not be suited for use 
in an animal model or ultimately for use in humans.  Although the material was sufficient 
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for use in short term studies involving blood and biological tissues, the long term 
biological effects are unknown.  The results of the hemolysis testing suggest that the 
material has a negligible effect on hemolysis although the exposure time was only one 
hour. 
Additionally, RTV11 was used for its flexibility.  The cross sections used in this 
study were solid and therefore if the same material was used for construction of the 
DBC, the tubing would easily collapse under pressures found in the circulatory system.  
Also, the material used is a two part compound which is difficult to use in large scale 
production. 
A suitable material for the DBC would need to be a flexible bio-inert plastic which 
is easily molded using injection molding or extrusion forming processes.  The DBC 
could be made of a number of silicone polymers which are currently used in biodevices.  
The flexibility of the DBC is needed to enable the outflow cannula to be easily pushed to 
the center of the aortic valve.  This is to allow the valve to seal against the cannula as it 
did during this study.  Additionally, the material should be selected so that it does not 
react with the body.  Materials which harm the tissue or which cause hemolysis and 
thrombogenesis are to be avoided.  A bio-reactive material, such as an endothelial cell 
scaffolding could be used, but may cause complications with attaching to adjacent 
tissues and changing the properties of the material.  Ideally, a bio-inert polymer would 
enable the cannulae to function as a conduit for blood and have a small impact on the 
body’s chemistry.  Finally, the material should be chosen so that large scale 
manufacture of the DBC is possible by conventional means.   
The DBC could be made by injection or extrusion molding techniques common in 
production of large quantities of plastic products.  There are several technical issues 
which would need to be considered for either method.  First, is whether the ideal 
material for the DBC is suitable for injection or extrusion molding.  The next issue is that 
the features of the DBC make both injection and extrusion molding difficult.  The use of 
injection molding would need to employ a removable core in order to leave the final 
product hollow.  Two ways in which this could be accomplished would be to either use a 
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dissolvable insert or to have a mold with a moveable core so that the finished piece 
could be removed from the mold.  The use of extrusion molding is ideal for the complex 
dual lumen shape, but makes the separation and tip design more difficult to 
manufacture.  These issues would need to be considered along with the material 
selection in order to make large scale production feasible.   
4.6.2 Interaction with the Heart 
One of the unknown factors is how the DBC would behave in a moving heart.  It 
is unknown if the DBC would stay in place during the heart’s rotation and contraction 
each beat.  The DBC will need to be able to withstand the twisting and bending applied 
by the ventricle without hampering the ventricle’s pumping.  Also, the constant cyclic 
loading of the DBC could cause degradation of the cannula and this should be 
considered for further design modifications of the DBC. 
Additionally, for both the occluded valve leaflet and triangular cross sectional 
geometries, the sharp corners inherent in those designs may cause inflammation and 
other issues when in contact with biological tissues.  The radius of these corners needs 
to be carefully considered in order to both maintain the intended shape of the cannula 
while not causing damage due to the sharpness of the corners. 
4.6.3 Thrombogenesis  
Due to the DBC’s positioning in the heart, there is the possibility of having areas 
where stagnant blood could settle and clot.  This is an unwanted outcome of interfering 
with the natural flow of blood in the ventricle.  The design could be altered to reduce this 
effect if it becomes an issue in animal testing and further investigations. 
During testing, clotting was noticed on the supporting felt used to secure the 
aortic valve in the flow loop.  This is despite the fact that anticoagulants were used to 
prevent the blood from clotting.  It is also important to note that no thrombi were found 
on the aortic valve or cannulae during experimentation, although further animal testing 
should be conducted to quantify the cannula’s role in thrombogenesis.   
64 CEZO 
 
Determining the cannula’s effect on thrombogenesis would require testing in an 
animal model for three reasons.  First, the blood used was infused with sodium citrate 
which is known to inhibit the coagulation of blood.  This is a necessary step for using the 
blood in the in vitro experiment used in the study in order to allow prolonged storage 
and analysis of the blood.  If the blood was used without sodium citrate, it is possible 
that most the blood would be coagulated before reaching the lab due to physical 
agitation of the blood during transport.  Second, the mechanism for coagulation is 
complex and is regulated by several chemical processes which would be difficult or 
impossible to mimic in vivo.  Third, long term studies on blood in a bench top flow loop 
are not possible due to the inability of preserving the blood.  Therefore, the 
thrombogenesis of the DBC would be more conclusively determined using an animal 
model test. 
4.7 Surgical Considerations 
Due to the limits of what can be emulated in an in vitro experiment, there are still 
some questions about what may affect the cannula’s effectiveness.  The development 
of new surgical tools and techniques may help bring the DBC to fruition.  These 
techniques and tools may also differ between the several cross-sectional geometries 
tested in this study.   
Specifically, the occluded valve leaflet geometry would need a way to secure it to 
the wall of the aortic valve without inhibiting the other two leaflets.  The occluded valve 
leaflet geometry was the most difficult to place in the experimental flow loop and 
therefore suggests that it may require additional attachments to the cardiac tissue as 
compared to the circular and triangular geometries. 
There are several approaches to securing the cannulae surgically.  The cannulae 
need to be secured to the left ventricular apex as well as inside the ventricle and 
possibly to the aorta.  The connection to the left ventricular apex could be done by 
conventional means or by a yet to be developed method.  The conventional cannula 
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attachment to the left ventricular apex involves suturing a felt ring to the cardiac tissue 
via horizontal mattress stitches. 
Some of the additional attachment that the DBC may need to function as 
intended would be to anchor the cannula to the interventricular septum and the aorta.  
How the DBC would attach to these areas is still being developed.   
The purpose of these additional attachment points would be to provide 
mechanical support to the interventricular septum and to align the cannula in the aortic 
valve.  The reason the DBC would provide support to the interventricular septum is to 
prevent left ventricular collapse due to VAD support.  The VAD can cause negative 
gage pressure in the ventricle and this in turn causes the muscle to collapse on itself.   
With the ventricle collapsed, the natural output of the ventricle is decreased and the 
possibility of occluding the VAD inlet is increased.  Additionally, these attachments 
could serve to align the DBC in the aortic valve.  The attachment at either the 
interventricular septum or the aorta could be used for this purpose.  Although the DBC 
is designed to self center, it may be necessary to further align the cannula through rigid 
attachment to the tissue.  
Another aspect to consider surgically is where the cannula should outlet to the 
aorta.  This is important in order to provide sufficient blood flow to all the arteries of the 
upper extremities as well as the coronary arteries.  If the outlet is too close to the aortic 
valve there is a chance that the flexible cannula could be pushed back into the ventricle, 
which would result in catastrophic failure of the device.  If the outlet extends long past 
the aortic valve, the blood flow to the upper extremities and coronaries might be 
reduced.  Exact length and proper placement of the outflow would vary from patient to 
patient, but the outlet of the cannula should extend no further than the aortic arch, 
where the first bifurcation of the arteries of the upper extremities is located.  This should 
provide enough length of cannula downstream of the aortic valve to prevent the cannula 
from collapsing into the ventricle while providing sufficient flow to the upper extremities.   
Finally, the cannulae would have to be available in several sizes in order to be 
successfully used in a wide array of patients.  The size of patients’ hearts and aortic 
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valves can vary considerably and the DBC needs to be able to accommodate this 
variation.  The DBC’s size will also depend on the amount of VAD support the patient 
needs.  The optimal size cannula would be one which compromises making the cannula 
small enough as to cause the least disturbance to the aortic valve and making the 
interior diameter large enough to reduce the pressure losses across the cannula, and 
therefore the work done by the VAD.  Conventional cannulae and catheters come in a 
few sizes in order to account for patient to patient size variation and VAD loading.  
Ideally, the size needed would be selected prior to implantation by correctly sizing the 
patient’s heart and aortic valve.  During the implantation the surgeon would have the 
choice of several sizes in cannula in order to determine which the best fit is for each 
patient.  This is common practice when implanting conventional cannulae. 
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Appendix A: Aortic Valve Dissection 
 
In order to isolate and separate the aortic valve from the rest of the cardiac 
tissue, a dissection was performed.  The heart was first bisected transversely to divide 
the inferior and superior sections of the heart.  Take the superior portion of the 
remaining heart and cut back the right ventricle along the interventricular septum, 
making sure to not cut through the septum.  Then cut through the tricuspid valve and 
remove the right atrium.  You are now left with the pulmonary trunk, aortic root, left 
ventricle, and left atrium.  Carefully identify the coronary arteries which originate from 
the sinus of valsalva at the base of the aortic root.  Cut the right coronary, left coronary, 
and circumflex arteries 1 cm from the sinus and keep these vessels intact until the valve 
is fully separated from the rest of the cardiac tissue.  Proceed by carefully bisecting the 
mitral valve along the mitral commissures.  Close attention must be paid to not injure 
the posterior portion of the mitral valve since the aortic valve lies directly behind it.  With 
mitral valve bisected remove the left atrium.  Next, separate the pulmonary trunk and 
aortic root by cutting the connective tissue and ligamentum arteriosum.  Now cut along 
the base of the aortic valve (aortic annulus) and remove the remaining left ventricular 
muscle.  Also, trim the remaining mitral valve leaflet to the aortic annulus.  Now the 
aortic valve and aortic root are separated and can be trimmed to size.  Cut the aortic 
root 5mm superior to the sinotubular junction.  Trim the coronaries to about 5mm to 
leave enough room to suture the coronaries closed without altering the shape of the 
sinus.  Rinse the valve with Phosphate Buffered Saline (PBS).  The aortic valve is now 
separate and ready for further preparations (Massey) (Bell and Bell) (Marieb and 
Hoehn) (Aortic Valve Replacement). 
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Appendix B: Spectrophotometer Setup 
 
Turn the spectrophotometer on and allow the machine to warm up for a few 
minutes. Press the ‘Change Mode’ button until the upper left hand corner of the screen 
reads ‘Absorbance’. Press ‘Set nm’ button and adjust the absorbance wavelength (λa) to 
540 nm.  Pipette 2 mL of Drabkin’s reagent and 1 mL of Distilled water into a plastic 
cuvette; this is the ‘0% Hemoglobin’ sample. Pipette 3 mL of Distilled water into a plastic 
cuvette; this is the ‘Blank’ sample.  Wipe sides with a Kimwipe and stir the mixture until 
it has a uniform color.  Open the lid on the spectrophotometer and place the ‘Blank’ 
cuvette in the slot labeled ‘B’ making sure that the arrow on the cuvette aligns with the 
notch in the slot.  Take the ‘0% Hemoglobin’ sample and place it in the slot labeled ‘1’.  
Close the lid on the spectrophotometer.  Press the ‘B’ button, and make sure that the 
absorbance reading reads 0.000.  This ensures that the spectrophotometer is 
functioning properly.  If the ‘Blank’ sample produces any other reading, consult manual 
for troubleshooting.  Next press the ‘1’ button and allow 10 seconds for the machine to 
take absorbance reading.  The value on the screen is the absorbance of the mixture at 
540 nm with 0% hemoglobin present in the sample.  Press the ‘Set as Blank’ button, 
and now the absorbance should read as 0.000.   The spectrophotometer is now ready 
to read samples from the hemolysis testing. 
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Appendix C: Labview User Interfaces and Block Diagrams 
 
 
Figure 37 - User Interface for Data Acquisition Program 
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Figure 38 - Block Diagram for Data Acquisition Program 
 Aortic Valve Performance with Transaortic Ventricular Cannula VII 
 
  
Figure 39 - PVS Controller User Interface 
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Figure 40 - PVS Controller Block Diagram 
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Appendix D: Pressure Transducer Analysis 
 
In section 2.7.1’Pressure’ the analysis of the pressure tap and transducer is 
discussed.  Following are the derivations for the equations used in that section to 
determine the settling time of the system. 
In order to use the RLC governing equation, we need to write the electrical 
components into their respective fluid analogies.   
Equation 11 - RLC Circuit 2nd Order Ordinary Differential Equation 
E << +  G  + H = 0 
Starting with the definition for electrical inductance, the fluid analogy can be 
derived.  By drawing between the similarities between the voltage across an electrical 
inductor and Newton’s second law of motion, the inductance of the fluid can be derived.  
Please note that the bold variables are used to show how the equations relate and 
serve to define the fluid inductance, resistance, and capacitance. 
 = m  
n = "   
o
 L <4 =  J K L 
<
4  p  
o
 =  q r st uv     
The o
 term is equivalent to the voltage drop across an inductor and the 
volumetric flow rate Q is equivalent to the current, therefore the inductance of the flow is 
the following equation.  
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Equation 12 - Fluid Inductance 
E = 4 J KL< 
 
Similarly, the resistance can be modeled using Ohm’s law and the equation for 
pressure drop due to laminar flow in a pipe. 
 = w  
o
 = 32 Q K< p = yvz { st uq  
Again, the pressure drop relates to the voltage and the volumetric flow rate 
equates to current. 
Equation 13 - Fluid Resistance 
GM@98N@7 = 128 Q KL# 
The capacitance of the system comes solely from the transducer itself.  The fluid 
capacitance comes from conservation of mass in order to draw similarities from the 
equation for voltage across a capacitor. 
 =  1H |   
J p L <4 =   (J ) 
The left hand side is the mass flow rate entering the transducer and the right 
hand side is the change in total mass of the system.  Differentiating reveals the 
following equation. 
 =   + J  J  
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The volume, V, is also a pressure dependent function since the transducer 
diaphragm deforms under pressure.  Therefore the volumetric change over time can be 
defined as follows.  
 =  
  
  
Additionally, since the fluid is incompressible, the density will not change over 
time and therefore negating the second term from the right hand side. 
 =  
  
  
Since A}A5 is a constant for the transducer defined as maximum displacement 
volume over pressure range, we can integrate the expression with the initial condition 
P=0. 

 =  ~~  |   
Comparing this equation with the voltage across a capacitor and the fluid 
capacitance can be determined.  The voltage and change in pressure can be related 
along with the volumetric flow rate and current. 
 =  1 |   
Equation 14 - Fluid Capacitance 
HRNDS9T76UU8VW6 =  
 
Using these derivations the pressure tap and transducer system can be modeled.  
Although the fluctuation noticed experimentally are pressure fluctuations and the system 
model examines volumetric flow rate through the system the two can be correlated.  
The importance of modeling the system was to determine the settling time of the 
system.  When the system comes to a steady state, the flow rate in the pressure taps 
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will be zero and the pressure will be constant.  Therefore it is reasonable to examine the 
settling time of the flow rate even though it is the pressure measurements which is 
analyzed in section 2.7.1 (Aerts, Carbonaro and Van den Braembussche, Chapter III - 
Pressure Measurments). 
 
 
 
